Recent Quotes (30 days)

You have no recent quotes
chg | %

AstraZeneca plc news

   Watch this stock
Showing stories 1 - 10 of about 179   

Articles published

AZN 4,327.50 -7.00 (-0.16%)
price chart
What Happens If Pfizer Inc. Doesn't Come Back For AstraZeneca plc?
Since May, AstraZeneca's (LSE: AZN) (NYSE: AZN.US) shareholders have been excitedly awaiting the return of Pfizer to make a new buyout offer for the UK's second largest pharmaceutical company.
GlaxoSmithKline PLC vs AstraZeneca PLC: Which Is The Better Dividend Play?  Yahoo Finance UK
Overheard: Astra's Payout Pipeline  Wall Street Journal
Related articles »  
Why Have GlaxoSmithKline plc And AstraZeneca plc Followed The FTSE 100 ...
Investors tend to turn to big blue-chip dividend payers at times of market volatility, and in times past the steady earnings of pharma giants GlaxoSmithKline (LSE: GSK) and AstraZeneca (LSE: AZN) have been a particular source of comfort when the market ...
AstraZeneca plc (AZN) Receives Posiitive Opinoin from CHMP for Lynparza
AstraZeneca plc (NYSE: AZN) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the marketing authorisation of Lynparza� (olaparib) as ...
AstraZeneca Ovarian-Cancer Drug Wins EU Agency's Backing  Businessweek
Related articles »  
Is Now The Right Time To Buy AstraZeneca plc?
After all, AstraZeneca's share price has fallen by 6% since 23 September, when changes to US tax rules made a bid less financially attractive for US companies.
Related articles »  
Is AstraZeneca plc A Promising Capital-Growth Investment?
astrazeneca2 The pharmaceutical industry continues to attract for its 'defensive' qualities and AstraZeneca (LSE: AZN) (NYSE: AZN.
Why I'd Still Buy AstraZeneca plc Despite Shire PLC Deal Collapse
2014 has been a superb year for investors in AstraZeneca (LSE: AZN). That's because shares in the pharmaceutical company have risen by 19% since the start of the year, which is well ahead of the FTSE 100′s disappointing decline of 6%.
Related articles »  
Why Smith & Nephew plc's Latest Failure Should Worry AstraZeneca plc And ...
Medical play Smith and Nephew (LSE: SN) disappointed the market on Monday when it announced that testing of its GlaxoSmithKline HP802-247 treatment in North America - a spray designed to treat veinous leg ulcers (or VLUs) - had failed at the Phase ...
Why You Should Let AstraZeneca plc Look After Your Money
AstraZeneca (LSE: AZN) (NYSE: AZN.US) is one of the world's largest pharmaceutical companies. It's produced some valuable products over the years, and that (if all goes well) looks set to continue.
Why Shire PLC, Hikma Pharmaceuticals Plc And BTG plc Could Complement ...
Of course, an obvious choice in the sector is AstraZeneca (LSE: AZN), due to its size, scale and improving pipeline. Indeed, the company is making significant improvements to its long term growth potential and has been on something of an acquisition ...
Related articles »  
Can AstraZeneca plc Help You To Retire Rich?
It's been an incredible turnaround for investors in AstraZeneca (LSE: AZN) (NYSE: AZN.US) in recent years. Indeed, after posting next to no share price gains between 2010 and 2013, shares in the pharmaceutical major have risen by 49% since the start of ...